Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Hospitalization 28% Improvement Relative Risk Hospitalization (b) 34% Hamer et al. Exercise for COVID-19 Prophylaxis Does physical activity reduce risk for COVID-19? Retrospective study in the United Kingdom Lower hospitalization with higher activity levels (p=0.0004) Hamer et al., Brain, Behavior, and Immunity, doi:10.1016/j.bbi.2020.05.059 Favors exercise Favors inactivity
Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK
Hamer et al., Brain, Behavior, and Immunity, doi:10.1016/j.bbi.2020.05.059
Hamer et al., Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study.., Brain, Behavior, and Immunity, doi:10.1016/j.bbi.2020.05.059
Jul 2020   Source   PDF  
  All Studies   Meta
UK Biobank retrospective analysis of 387,109 people, showing lower risk of COVID-19 hospitalization with physical activity.
risk of hospitalization, 27.5% lower, RR 0.72, p < 0.001, adjusted per study, inverted to make RR<1 favor high activity levels, model 2, sufficient vs. no activity, multivariable.
risk of hospitalization, 33.8% lower, RR 0.66, p < 0.001, adjusted per study, inverted to make RR<1 favor high activity levels, model 1, sufficient vs. no activity, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hamer et al., 31 Jul 2020, retrospective, United Kingdom, peer-reviewed, 4 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperExerciseAll
Abstract: Brain, Behavior, and Immunity 87 (2020) 184–187 Contents lists available at ScienceDirect Brain, Behavior, and Immunity journal homepage: Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK T Mark Hamera,⁎, Mika Kivimäkib, Catharine R. Galec,d, G. David Battyb a Division of Surgery and Interventional Sciences, Faculty Medical Sciences, University College London, London, UK Department of Epidemiology and Public Health, University College London, UK c MRC Lifecourse Epidemiology Unit, University of Southampton, UK d Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, UK b ARTICLE INFO ABSTRACT Keywords: Physical activity Smoking Obesity Infection Coronavirus C-reactive protein Population cohort We conducted the first large-scale general population study on lifestyle risk factors (smoking, physical inactivity, obesity, and excessive alcohol intake) for COVID-19 using prospective cohort data with national registry linkage to hospitalisation. Participants were 387,109 men and women (56.4 ± 8.8 yr; 55.1% women) residing in England from UK Biobank study. Physical activity, smoking, and alcohol intake, were assessed by questionnaire at baseline (2006–2010). Body mass index, from measured height and weight, was used as an indicator of overall obesity. Outcome was cases of COVID-19 serious enough to warrant a hospital admission from 16-March-2020 to 26-April-2020. There were 760 COVID-19 cases. After adjustment for age, sex and mutually for each lifestyle factor, physical inactivity (Relative risk, 1.32, 95% confidence interval, 1.10, 1.58), smoking (1.42;1.12, 1.79) and obesity (2.05 ;1.68, 2.49) but not heavy alcohol consumption (1.12; 0.93, 1.35) were all related to COVID19. We also found a dose-dependent increase in risk of COVID-19 with less favourable lifestyle scores, such that participants in the most adverse category had 4-fold higher risk (4.41; 2.52–7.71) compared to people with the most optimal lifestyle. C-reactive protein levels were associated with elevated risk of COVID-19 in a dose-dependent manner, and partly (10–16%) explained associations between adverse lifestyle and COVID-19. Based on UK risk factor prevalence estimates, unhealthy behaviours in combination accounted for up to 51% of the population attributable fraction of severe COVID-19. Our findings suggest that an unhealthy lifestyle synonymous with an elevated risk of non-communicable disease is also a risk factor for COVID-19 hospital admission, which might be partly explained by low grade inflammation. Adopting simple lifestyle changes could lower the risk of severe infection.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop